Cellares
Builds infrastructure intended to expand access to cell therapies and support delivery of advanced treatments to more patients.
Overview
Cellares is focused on expanding patient access to cell therapies. The company operates in the cell therapy supply chain, serving a healthcare market where manufacturing capacity, reliability and cost can constrain adoption. Its current funding context is a $277 million undisclosed round announced on June 10, 2026, with Cathie Wood’s ARK Invest joining the financing. The capital is intended to help bring cell therapies to more patients, positioning Cellares as a scaled deep-tech life sciences platform rather than a pure AI software business.
Funding History
Cathie Wood’s ARK Invest joins Cellares’ $277M round to help bring cell therapies to more patients
Frequently Asked Questions
- How much funding does AI Funding track for Cellares?
- AI Funding tracks $277M for Cellares across 1 funding round in this database.
- Who are Cellares's investors?
- Cellares's investors include BlackRock, Eclipse, Baillie Gifford, DFJ Growth, Gates Frontier, and 7 others.
- What does Cellares do?
- Cellares is focused on expanding patient access to cell therapies. The company operates in the cell therapy supply chain, serving a healthcare market where manufacturing capacity, reliability and cost can constrain adoption. Its current funding context is a $277 million undisclosed round announced on June 10, 2026, with Cathie Wood’s ARK Invest joining the financing. The capital is intended to help bring cell therapies to more patients, positioning Cellares as a scaled deep-tech life sciences platform rather than a pure AI software business.
- Where is Cellares headquartered?
- Cellares is headquartered in South San Francisco, United States.
Investors
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.